What this is
- This research investigates the roles of Period2 (Per2) and Period3 (Per3) genes in the mouse circadian system.
- Using C57BL/6J congenic mice, the study assesses wheel-running activity and gene expression in various tissues.
- Findings reveal distinct functions for Per2 and Per3, suggesting tissue-specific roles in circadian rhythm regulation.
Essence
- Per2 influences in the (), while Per3 affects rhythms in the pituitary and lung. The study reveals that Per2(-/-) mice show a 1.5-hour shorter period of Per1-luc expression in explants, despite only an 11-minute difference in wheel-running activity.
Key takeaways
- Per2(-/-) mice exhibit a 1.5-hour shorter period of Per1-luc expression in explants compared to Per2+/+ mice. This indicates that Per2 plays a crucial role in determining the circadian period within the .
- Wheel-running activity in Per2(-/-) mice is only 11 minutes shorter than in Per2+/+ mice. This discrepancy suggests that the effects of Per2 on behavior may be moderated by other factors in vivo.
- In contrast, Per3(-/-) mice show no differences in rhythms but exhibit significant alterations in the pituitary and lung. This points to a tissue-specific role for Per3 in circadian timekeeping.
Caveats
- The study primarily focuses on specific genetic backgrounds, which may limit the generalizability of the findings. Results in C57BL/6J mice may not apply to other strains.
- The research relies on in vitro assessments, which may not fully capture the complexities of in living organisms.
Definitions
- Circadian rhythms: Self-sustained physiological and behavioral oscillations with periods of approximately 24 hours, influenced by environmental cues.
- Suprachiasmatic nuclei (SCN): A group of neurons in the anterior hypothalamus that serves as the primary circadian pacemaker in mammals.
AI simplified
Introduction
Circadian rhythms are self-sustained oscillations in physiology and behavior with endogenous periods of approximately 24 hours that can be entrained to environmental cues such as the light/dark cycle and temperature [1]. In mammals, a light-entrainable circadian pacemaker, located in the suprachiasmatic nuclei (SCN) of the anterior hypothalamus, plays a critical role in the generation of daily rhythms. Surgical destruction of the SCN abolishes most circadian rhythms, including rhythmic locomotor activity [2], [3], [4]. Transplants of fetal SCN tissue to SCN-lesioned animals restore rhythmic behavior that is consistent with the periodicity of the donor's genotype [5], [6], [7], suggesting that the SCN controls the period of the circadian behavioral rhythm.
The SCN is not the only endogenously rhythmic structure. Ex vivo adrenals, liver, and retinas exhibit circadian rhythmicity [8], [9], [10], [11], [12]. In addition, genes important for circadian timekeeping are expressed not only in the SCN, but also in many peripheral tissues [13], [14], [15], [16], [17]. Following the discovery that immortalized rat embryonic fibroblasts have circadian rhythms of gene expression [18], real-time monitoring of circadian promoter-driven reporters revealed that peripheral tissues and extra-SCN brain regions exhibit circadian oscillations in vitro[19], [20], [21]. Consequently, there is now direct evidence that the mammalian circadian system is composed of multiple circadian oscillators: a light-entrainable central pacemaker in the SCN and many oscillators in other regions of the brain and peripheral tissues.
The molecular mechanism of endogenous rhythm generation in the SCN is modeled as interlocking positive and negative transcriptional and translational feedback loops of circadian gene expression [22], [23], [24]. According to this model, BMAL1/CLOCK or BMAL1/NPAS2 heterodimers activate the transcription of the Period (Per) and Cryptochrome (Cry) genes. As PER and CRY proteins accumulate, they form complexes and directly bind to BMAL1-CLOCK/NPAS2 heterodimers, thereby inhibiting their own transcription. In addition, post-translational modifications regulate the stability and cellular localization of circadian proteins. The mRNAs of three Period homologs (Per1, 2, and 3) are rhythmically expressed in the SCN, yet only Per1 and Per2 have been implicated as important negative elements in the feedback loops that generate the endogenous SCN rhythm [14], [15], [17], [25], [26], [27]. Per1β/β or Per2β/β mice, for example, have more severe behavioral phenotypes than Per3β/β mice. The periods of wheel-running activity of Per1β/β and Per2β/β mice can be 1.5 hrs shorter than wildtype mice (depending on the line and genetic background) and they sometimes become arrhythmic in constant darkness (DD), while only a 0.5 h period difference between Per3β/β and wildtype mice has been observed and Per3β/β mice never become arrhythmic in DD [28], [29], [30], [31], [32]. In addition, Per1/Per2 double mutants, but not Per1/Per3 or Per2/Per3 double mutants, have arrhythmic locomotor activity in DD [28]. While most of these experiments have been performed in mice with mixed genetic backgrounds or congenic with the 129/sv strain, one study found that Per2β/β mice congenic with the C57BL/6J strain have periods of wheel-running activity that are indistinguishable from wildtype mice and they do not become arrhythmic in DD [33].
The C57BL/6J strain is ideal for analysis of circadian behavior because the mice have high amplitude (robust), consolidated (not dissociated or fragmented) locomotor activity with a stable free-running period in DD [34], [35]. Since the phenotypes of Per mutant mice may vary depending on the genetic background, we sought to investigate the circadian phenotypes of wheel-running behavior and of SCN and peripheral tissue explants in Per2β/β and Per3β/β mice congenic with the C57BL/6J strain. In our previous study of C57BL/6J Per1β/β mice, we found that the real-time circadian gene promoter activity rhythm was weak or absent in SCN slices in vitro even though the free-running wheel-running activity rhythm was indistinguishable from wildtype mice [36]. Pituitary and lung explants were also arrhythmic in C57BL/6J Per1β/β mice. In the current study, we assessed wheel-running activity and rhythmicity in the SCN and peripheral tissues in Per2β/β and Per3β/β mice congenic with the C57BL/6J strain. Our approach allowed us to compare the behavioral rhythms to the rhythms of explanted tissues of Per2β/β and Per3β/β mice with genetic background held constant.
Results
Circadian Wheel-Running Behavior of C57BL/6JandMice Per2 β/β Per3 β/β
We generated Per2β/β and Per3β/β mice congenic with the C57BL/6J strain by backcrossing mPer2β/β and mPer3β/β mutants on an inbred 129/sv genetic background [28], [32] for 10 to 11 generations with C57BL/6J wildtype mice (The Jackson Laboratory, Bar Harbor, ME). We found that Per2β/β mice had a significantly shorter period of locomotor activity (by βΌ11 minutes) compared to Per2+/+ and Per2+/β mice (F2, 28 = 5.61, p<0.01, LSD p<0.05; Figure 1A, C, E). In contrast, the period of wheel-running activity in Per3β/β mice did not differ from Per3+/+ controls (t17 = 1.26, p = 0.22; Figure 1B, D, E). The phase angle of entrainment was significantly advanced by 25 minutes in Per2β/β mice compared to Per2+/+ and Per2+/β mice (F2, 28 = 8.13, p<0.01, LSD p<0.05; Figure 1F). The phase angle of entrainment of Per3β/β mice did not differ from Per3+/+ mice (t17 = 0.18, p = 0.86; Figure 1F). Total activity levels and the amplitudes (Qp) of wheel-running activity in Per2β/β and Per3β/β mice were indistinguishable from wildtype controls (Table 1). The Qp of wheel-running activity in Per2+/β mice was significantly greater than in Per2+/+ and Per2β/β mice (F2, 28 = 3.77, p = 0.04, LSD p<0.05; Table 1). None of the mice in our study became arrhythmic even after 3 weeks in DD.

Characterization of Circadian Behavior in C57BL/6JandMice. Per2 β/β Per3 β/β Representative double-plotted actograms of wheel-running activity of(A; nβ=β10),(B; nβ=β10),(C; nβ=β12), and(D; nβ=β10) mice maintained in 12LβΆ12D LD (lights on at 0 h and lights off at 12 h) for 7 days and then released into constant darkness (DD). The free-running period was determined by using Οperiodogram for days 1-15 in DD (E). The phase angle of entrainment (F) was determined by drawing a regression line to activity onset for days 1-5 in DD and then extending the regression line to the last day in LD. A negative phase angle was obtained when activity started before the time of lights off and a positive phase angle was obtained when activity started after the time of lights off. Data are the meanΒ±SD; *<0.05. Per2 +/+ Per3 +/+ Per2 β/β Per3 β/β p 2
| Genotype | Mean (revs/day) | SD | n | p | |
| Activity/day | Per2+/+ | 3726.37 | 1618.62 | 9 | =β2.12,=β0.14Fp2, 28 |
| Per2+/β | 4713.71 | 756.35 | 8 | ||
| Per2β/β | 3410.36 | 1558.6 | 12 | ||
| Per3+/+ | 4797.62 | 931.28 | 9 | =β0.96,=β0.35t17p | |
| Per3β/β | 4257.75 | 1428.48 | 10 | ||
| Genotype | Mean | SD | n | p | |
| Qp | Per2+/+ | 1793.54 | 658.27 | 9 | =β3.77,=β0.04Fp2, 28 |
| Per2+/β | 2466.54 | 184.55 | 8 | LSD<0.05 a p | |
| Per2β/β | 1805.2 | 685.741 | 12 | ||
| Per3+/+ | 2304.96 | 423.78 | 9 | =β1.08,=β0.30t17p | |
| Per3β/β | 2063.37 | 538.76 | 10 |
Lack of Functional PER2 Affects the Circadian Rhythm in C57BL/6J SCN Explants
We next assessed Per1-luc expression in cultured SCN explanted from Period mutant mice (Figure 2). Per2β/β SCN explants exhibited robust rhythmicity, but the period of Per1-luc expression was significantly shorter than in SCN from Per2+/+ and Per2+/β mice (F2, 14 = 11.61, p<0.01, LSD p<0.01; Figure 2A, C). There was also a trend for the phase of the Per1-luc expression rhythm in Per2β/β SCN explants to be advanced compared to Per2+/+ and Per2+/β SCN (F2, 14 = 3.83, p = 0.05; Figure 2D).
Per1-luc expression in Per3β/β SCN explants was indistinguishable from Per3+/+ SCN. The period (t6 = 1.17, p = 0.29; Figure 2B, C) and phase (t7 = β0.28, p = 0.79; Figure 2D) of Per1-luc expression in Per3β/β SCN did not differ from Per3+/+ SCN.
Baseline Per1 promoter activity in the SCN was also altered by loss of Per function. In SCN explants, Per1 promoter activity was elevated in Per2β/β and Per3β/β mice compared to wildtypes and heterozygotes (Figure 3A), suggesting that PER2 and PER3 may inhibit the activation of the Per1 promoter in wildtype SCN.

Expression in SCN Explants from C57BL/6JandMice. Per1-luc Per2 β/β Per3 β/β Representative baseline-subtracted bioluminescence rhythms in SCN explants from(black trace; A; nβ=β5) and(red trace; A; nβ=β6) mice and from(black trace; B; nβ=β4) and(red trace; B; nβ=β5) mice. The lighting condition of the previous light/dark cycle is indicated for the first day; open bars are light and black bars are dark. (C) The period was determined by fitting a regression line to the acrophase of the-rhythm. (D) The phase was designated as the first peak ofexpressionand is plotted relative to the light-dark cycle before culture, where 0 h is the time of lights on and 12 h is the time of lights off (only the subjective day is shown). All data are presented as the meanΒ±SD; **<0.01. Per2 +/+ Per2 β/β Per3 +/+ Per3 β/β Per1 luc Per1-luc in vitro p
![Click to view full size Promoter Activity Is Altered in PER-deficient Tissues. Per1 Averagebioluminescence (raw data) from SCN explants (A) and whole pituitary glands (B) from wildtype, heterozygous, or PER-deficient mice. Bioluminescence data frommice were taken from. The lighting condition of the previous light/dark cycle is indicated for the first day; open bars are light and black bars are dark. Per1-luc Per1 β/β [[36]]](https://europepmc.org/articles/PMC2804141/bin/pone.0008552.g003.jpg.jpg)
Promoter Activity Is Altered in PER-deficient Tissues. Per1 Averagebioluminescence (raw data) from SCN explants (A) and whole pituitary glands (B) from wildtype, heterozygous, or PER-deficient mice. Bioluminescence data frommice were taken from. The lighting condition of the previous light/dark cycle is indicated for the first day; open bars are light and black bars are dark. Per1-luc Per1 β/β [[36]]
Circadian Rhythms in Pituitary and Lung Explants Are Altered inMice Per3 β/β
To determine if peripheral tissues have altered circadian rhythms in C57BL/6J Per2β/β and Per3β/β mice, we assessed Per1-luc expression in ex vivo pituitary glands and lungs (Figure 4). The period (H = 0.76, d.f. = 2, p = 0.68; Figure 4A, C) and phase (F2, 16 = 1.98, p = 0.18; Figure 4A, E) of Per1-luc expression in Per2β/β pituitary explants did not differ from Per2+/+ and Per2+/β mice.
The period of Per1-luc expression in Per3β/β pituitary explants was significantly shorter than in Per3+/+ pituitary (t7 = 2.43, p<0.05; Figure 4A, C). In addition, the phase of Per1-luc expression was significantly advanced in Per3β/β pituitary compared to Per3+/+ mice (t7 = 5.69, p<0.001; Figure 4A, E).
In pituitary explants, baseline Per1 promoter activity was elevated in Per2β/β and Per3β/β mice compared to wildtypes and heterozygotes (Figure 3B), suggesting that PER2 and PER3 may inhibit the activation of the Per1 promoter in wildtype pituitary.
There was a trend toward an elongated period of Per1-luc expression in lung explants from Per2β/β and Per2+/β mice compared to Per2+/+ mice (F2, 14 = 3.84, p = 0.05; Figure 4B, D). There was also a trend for Per2β/β lung explants to have a delayed phase of Per1-luc expression compared to Per2+/+ and Per2+/β lung (F2, 14 = 3.60, p = 0.06; Figure 4B, F).
In Per3β/β lung explants, the period was shorter (t7 = 2.53, p<0.05; Figure 4B, D) and the phase of Per1-luc expression was advanced (t7 = 2.61, p<0.05; Figure 4B, F) compared to Per3+/+ lung.

Expression in Peripheral Tissues Explanted from C57BL/6JandMice. Per1-luc Per2 β/β Per3 β/β Representative baseline-subtracted bioluminescence rhythms in pituitary (A) and lung (B) explants from(black trace; top panel; nβ=β6) and(red trace; top panel; nβ=β4-6) mice and from(black trace; bottom panel; nβ=β4) and(red trace; bottom panel; nβ=β5) mice. The lighting condition of the previous light/dark cycle is indicated for the first day; open bars are light and black bars are dark. The period of pituitary (C) and lung (D) explants was determined by fitting a regression line to the acrophase of the-rhythm. The phase of pituitary (E) and lung (F) explants was designated as the first peak ofexpressionand is plotted relative to the light-dark cycle before culture, where 0 h is the time of lights on and 12 h is the time of lights off (open bars are light and black bars are dark). All data are presented as the meanΒ±SD; *<0.05, ***<0.001. Per2 +/+ Per2 β/β Per3 +/+ Per3 β/β Per1 luc Per1-luc in vitro p p
Discussion
Previous studies have demonstrated that the SCN controls the period of the circadian locomotor activity rhythm in mammals [7], [37], [38]. Therefore, it is reasonable to predict that if a molecular alteration of the timekeeping mechanism changes the period of the circadian rhythm in the SCN, then the period of locomotor activity should also change (in a similar direction and magnitude). This hypothesis is supported by previous studies in tau mutant hamsters and Clock (Ξ19) mutant mice [39], [40], [41]. In contrast, we found that clock gene promoter-driven luciferase activity was arrhythmic or had low amplitude, irregular rhythms in SCN explants from C57BL/6J Per1β/β mice even though their locomotor behavior was indistinguishable from wildtype mice [36]. In the current study we assessed locomotor activity and rhythmicity in the SCN of Per2β/β and Per3β/β mice to determine if the in vitro phenotypes of the mutant SCN were congruent with behavior.
We found that the period of wheel-running activity was 11 minutes shorter and the phase angle of entrainment was advanced by 25 minutes in C57BL/6J Per2β/β mice compared to Per2+/+ mice. Since we observed only small differences in behavior between Per2β/β and Per2+/+ mice, we expected to observe a mild phenotype of Per1-luc expression in the Per2β/β SCN. Surprisingly, though, we found that the period of Per1-luc expression in the Per2β/β SCN was 1.5 hours shorter than in the Per2+/+ SCN. The period was shorter in both the SCN and behavior, but the Per2 mutant phenotype was enhanced in SCN explants. Since the phenotype was more pronounced in vitro compared to in vivo, we hypothesize that in vivo factors such as temperature fluctuations, activity feedback, or coupling to extra-SCN oscillators may compensate for the mutant phenotype.
To our knowledge, our study is the first to analyze real-time circadian rhythms of gene expression in SCN explants from Per2β/β mice. A previous study found that bioluminescence was arrhythmic or had low amplitude, irregular rhythms in immortalized fibroblasts derived from Per2β/β mice and infected with a lentiviral construct in which the Per2 promoter drives the expression of luciferase (mPer2-dluc) [42]. SCN explants (or dissociated SCN neurons) were not investigated using this lentivirally-mediated method [42]. In contrast to the dissociated Per2β/β fibroblasts analyzed by Liu et al. [42], we found that SCN, pituitary, and lung explants from C57BL/6J Per2β/β mice had robust, rhythmic expression of Per1-luc. While the period of Per1-luc expression in Per2β/β SCN explants was significantly shorter than in Per2+/+ SCN, circadian rhythms in ex vivo pituitary and lung from Per2β/β mice were largely unaffected compared to Per2+/+ mice.
In contrast to Per2β/β mice, wheel-running behavior and rhythmicity in the SCN of C57BL/6J Per3β/β mice were indistinguishable from Per3+/+ mice. Interestingly, though, we found that the period and phase of Per1-luc expression in the pituitary and lung were altered when PER3 was not functional. Our findings in Per3β/β SCN and lung explants are in agreement with a previous study that assessed the expression of the PERIOD2::LUCIFERASE fusion protein in ex vivo Per3β/β tissues [42]. Since we also found that circadian rhythms were altered in pituitary explants from Per3β/β mice compared to Per3+/+ mice, it is possible that Per3 is important for timekeeping in peripheral tissues. Future studies could assess the physiological outputs of peripheral tissues to determine if the in vitro phenotypes of Per3β/β tissues are present in vivo.
Taken together, our data suggest that the function of each Per gene may differ between tissues. Per2 appears to be important for period determination in the SCN, while Per3 participates in timekeeping in the pituitary and lung.
Materials and Methods
Animals
We obtained mPer2ldcβ/β and mPer3β/β mice [28], [32] (provided by Dr. David Weaver, University of MA, congenic with the 129/sv genetic background) and backcrossed the mice with wildtype C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) for 10 to 11 generations (C57BL/6J Per2β/β and Per3β/β mice are available from The Jackson Laboratory, stock #10492 and #10493, respectively). Heterozygous mice were then crossed with C57BL/6J Per1-luc transgenic mice (1-8L) [43] to generate mice that were heterozygous for the Period gene and for the Per1-luc transgene. Period heterozygous (without Per1-luc transgene) mice were then crossed with Period heterozygous mice with the Per1-luc transgene to generate wildtype, heterozygous, and homozygous mutant mice that expressed Per1-luc (N10 to N11) that were used for experiments. Genotype was determined by PCR amplification of tail DNA as previously described [28], [32]. The mice were bred and group-housed in the Vanderbilt University animal facility in a 12 h-light/12 h-dark cycle (12LβΆ12D) and provided food and water ad libitum. Male and female mice were used for assessing behavior and for preparing tissue explants. The ages at the beginning of the experiment (meanΒ±SD days) and sexes for each experimental condition are: Per2+/+ behavior: 37.8Β±10.0, 5 males/5 females; Per2+/β behavior: 89.3Β±60.1, 6 males/3 females; Per2β/β behavior: 49.3Β±17.2, 8 males/4 females; Per3+/+ behavior: 43.6Β±9.7, 4 males/6 females; Per3β/β behavior: 43.1Β±10.2, 5 males/5 females; Per2+/+ tissue: 66.3Β±7.7, 3 males/3 females; Per2+/β tissue: 77.0Β±9.3, 3 males/2 females; Per2β/β tissue: 64.3Β±21.1, 3 males/3 females; Per3+/+ tissue: 113.8Β±39.9, 3 males/1 female; Per3β/β tissue: 81.8Β±22.3, 4 males/1 female. All experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee at Vanderbilt University.
Analysis of Wheel-Running Activity
For experiments assessing wheel-running activity, mice were singly housed in cages (33Γ17Γ14 cm) with unlimited access to a running wheel (diameter: 11 cm), food, and water. The cages were placed in light-tight, ventilated boxes where the light intensity was 350 lux. Wheel running activity was monitored by a micro-switch-activated signal using the ClockLab system (Actimetrics, Wilmette, IL) and was collected by computer every minute. Analysis was performed using ClockLab software. Free-running period was determined by using a Ο2 periodogram for 15 days (days 1β15 in DD). The amplitude (Qp) of the wheel-running rhythm was the peak value of the Ο2 periodogram. Total activity level was determined by counting the total number of wheel revolutions from days 1β15 in DD and then averaging them to determine daily activity level. The phase angle of entrainment was defined as the time difference between activity onset and the predicted time of dark onset on the first day in DD. This was calculated by drawing a regression line to activity onset for days 1β5 in DD and then extending the regression line to the last day in LD. A negative phase angle was obtained when activity started before lights off and a positive phase angle was obtained when activity started after lights off.
Luminescence Recording
The detailed methods for real-time measurement of luminescence from ex vivo tissues have been described [44]. Coronal slices of the SCN (300 Β΅m) were prepared by trimming away most extra-SCN tissue and bioluminescence was measured using the LumiCycle apparatus. LumiCycle software (Actimetrics Inc., Wilmette, IL) was used to subtract the 24-hour moving average from the raw luminescence data and to smooth the data by 0.5-hour adjacent averaging. To determine period and phase, the baseline-subtracted and smoothed data was exported to ClockLab (Actimetrics Inc., Wilmette, IL). The period was determined by fitting a regression line to the acrophase of at least 3 days of the Per1-luc rhythm and the phase was determined from the first peak of Per1-luc expression in vitro.
Statistical Analysis
Statistical analysis was performed using SigmaStat (Systat Software, Inc., San Jose, CA). One-way ANOVA followed by post-hoc Fisher's least significant difference (LSD) tests were used for comparison of more than two groups and independent t tests (two-tailed) were used to compare two groups except when data was not normally distributed or variances were not homogeneous. The Kolmogorov-Smirnov test (with Lilliefors' correction) was used to test data for normality. For nonparametric analyses, the Kruskal-Wallis One-way ANOVA on Ranks followed by post-hoc Dunn's Method were used. Significance was ascribed at p<0.05.